tiprankstipranks
Vigil Neuroscience initiated with a Buy at Mizuho
The Fly

Vigil Neuroscience initiated with a Buy at Mizuho

Mizuho initiated coverage of Vigil Neuroscience with a Buy rating and $15 price target. While the analyst noted that the company is an early-stage story, the firm has enthusiasm for the company’s immuno-neurology-based approach, the lack of current direct competition, increased FDA/regulatory embracing of biomarker-based approaches for NDG disease, and the potential for accelerated clinical development timelines.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on VIGL:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles